GMED

NYSE Healthcare

Globus Medical, Inc. Class A Common Stock

Medical Devices

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

๐Ÿ“Š Market Data
Price$91.34
Volume906,981
Market Cap12.39B
Beta1.090
RSI (14-Day)46.6
200-Day MA$77.05
50-Day MA$90.17
52-Week High$101.40
52-Week Low$51.79
P/E Ratio23.30
Forward P/E18.45
Price / Book2.70
๐ŸŽฏ Investment Strategy Scores

GMED scores across each investment strategy. Higher is better for that strategy's goals.

High dividend yield + low volatility
๐Ÿš€ Moon Shot 71/100โ–ฒ +2
High growth potential (high beta + oversold)
๐Ÿ”ช Falling Knife 45/100โ€” 0
Contrarian plays (oversold + below moving average)
๐ŸŽˆ Over-Hyped 27/100โ–ผ -1
Overbought stocks (potential short candidates)
Large-cap, institutional-quality stocks
๐Ÿ” Strategy Interpretation

Best fit: ๐Ÿ‹ Institutional Whale (76/100) โ€” this strategy Large-cap, institutional-quality stocks.

Lowest fit among scored strategies: ๐Ÿ’ฐ Dividend Daddy (23/100). No single score is a buy or sell signal โ€” use multiple lenses together. Learn how to read these scores โ†’

Find GMED in your text

Paste any article, transcript, or post โ€” the tool will extract GMED and every other hidden ticker.

Try the Ticker Extractor โ†’

Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.